Holen Sie sich die Stockscreener-App
7.97
3.39%
-0.28
Schlusskurs vom Vortag:
$8.25
Offen:
$8.18
24-Stunden-Volumen:
305.64K
Relative Volume:
0.79
Marktkapitalisierung:
$442.94M
Einnahmen:
Nettoeinkommen (Verlust:
$-161.15M
KGV:
-2.1454
EPS:
-3.7149
Netto-Cashflow:
$-138.61M
1W Leistung:
-0.38%
1M Leistung:
-23.80%
6M Leistung:
-73.22%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$7.84
$8.58
52-Wochen-Spanne:
$7.46
$40.43
Maplight Therapeutics Inc Stock (MPLT) Company Profile
Firmenname
Maplight Therapeutics Inc
Sektor
Branche
Telefon
650-839-4360
Adresse
800 CHESAPEAKE DRIVE, REDWOOD CITY
Compare MPLT vs VRTX, REGN, MRNA, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MPLT
Maplight Therapeutics Inc
|
7.97 | 442.94M | 0 | -161.15M | -138.61M | -3.7149 |
VRTX
Vertex Pharmaceuticals Inc
|
523.93 | 132.80B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.02 | 82.88B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
200.10 | 79.89B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
873.71 | 54.94B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
377.63 | 42.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Maplight Therapeutics Inc Stock (MPLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-06 | Eingeleitet | Guggenheim | Neutral |
| 2026-08-10 | Herabstufung | UBS | Buy → Neutral |
| 2026-07-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-07-21 | Eingeleitet | BMO Capital Markets | Outperform |
| 2026-06-25 | Eingeleitet | Raymond James | Strong Buy |
| 2026-05-27 | Eingeleitet | UBS | Buy |
| 2026-05-21 | Eingeleitet | Craig Hallum | Buy |
| 2026-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2026-04-08 | Eingeleitet | Needham | Buy |
| 2026-04-07 | Eingeleitet | TD Cowen | Buy |
| 2026-03-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-11-21 | Eingeleitet | Jefferies | Buy |
| 2025-11-21 | Eingeleitet | Leerink Partners | Outperform |
| 2025-11-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-11-21 | Eingeleitet | Stifel | Buy |
Alle ansehen
Maplight Therapeutics Inc Aktie (MPLT) Neueste Nachrichten
MapLight Therapeutics’ Kreitzer sells $96,024 in common stock By Investing.com - Investing.com South Africa
MapLight Therapeutics CMO Erin Foff sells $124,068 in stock By Investing.com - Investing.com South Africa
Form 4 MapLight Therapeutics Inc: James Woodruff Lillie (Chief Scientific Officer) For: 15 October - Investing.com Nigeria
MapLight Therapeutics CMO Erin Foff sells $124,068 in stock - Investing.com
MapLight Therapeutics chief scientific officer sells $93,025 in shares - Investing.com
MapLight Therapeutics general counsel reports $72,881 stock sale - Investing.com
MapLight Therapeutics CAO sells $82,149 in shares - Investing.com
MapLight Therapeutics’ Kreitzer sells $96,024 in common stock - Investing.com
MapLight Therapeutics CAO sells $82,149 in shares By Investing.com - Investing.com UK
MapLight Therapeutics chief scientific officer sells $93,025 in shares By Investing.com - Investing.com UK
Form 4 MapLight Therapeutics Inc: Anatol Kreitzer (Chief Discovery Officer) For: 15 October - Investing.com Nigeria
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com Nigeria
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com India
Form 144 MapLight Therapeutics For: 16 October By Investing.com - Investing.com UK
MapLight Therapeutics Officer Christopher Kroeger Files to Sell 73,691 Shares to Cover RSU Tax Withholding - Kalkine Media
MapLight Therapeutics Officer Lillie James Woodruff to Sell 11,513 Shares for RSU Tax Withholding - Kalkine Media
MapLight Therapeutics Director Robert Malenka Announces Sale of 14,809 RSU Shares via Rule 144 - Kalkine Media
Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Nigeria
Form 4 MapLight Therapeutics Inc For: 26 September By Investing.com - Investing.com Australia
MapLight Therapeutics (MPLT) exec to sell shares under preset trading plan - stocktitan.net
MapLight Therapeutics, Inc. (MPLT) Stock Price Quote Today & Current Price Chart - Capital.com
MapLight Therapeutics to Participate in Upcoming Investor Conference - The Manila Times
BlackRock Inc. Takes $36.74 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Up 5.3%Here's What Happened - MarketBeat
Needham cuts MapLight Therapeutics price target on dilution concerns By Investing.com - Investing.com Canada
Needham cuts MapLight Therapeutics price target on dilution concerns By Investing.com - Investing.com India
Maplight Therapeutics (NASDAQ:MPLT) Price Target Lowered to $43.00 at Needham & Company LLC - MarketBeat
Freestone Grove Partners LP Makes New $6.05 Million Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Nan Fung Group Holdings Ltd Makes New $34.81 Million Investment in Maplight Therapeutics, Inc. $MPLT - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading Down 4.6%What's Next? - MarketBeat
Maplight Therapeutics (NASDAQ:MPLT) Trading 7.8% HigherShould You Buy? - MarketBeat
Maplight Therapeutics, Inc. (NASDAQ:MPLT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Segal Trials Reinforces Leadership in Acute Schizophrenia Research Following Participation in MapLight Therapeutics’ Phase 2 ZEPHYR Study - Business Wire
Blue Owl Capital Holdings LP Takes $26.16 Million Position in Maplight Therapeutics, Inc. $MPLT - MarketBeat
MPLT: MapLight Therapeutics, Inc.Financial Overview - Zacks Investment Research
MapLight Therapeutics (MPLT): Nan Fung group holds passive stake above 5% - Stock Titan
Maplight Therapeutics (NASDAQ:MPLT) Stock Price Down 7%Should You Sell? - MarketBeat
MapLight Therapeutics (MPLT) grants CDO 24K options and 6K RSUs - stocktitan.net
MapLight (NASDAQ: MPLT) grants CEO 93,955 options and 23,145 RSUs - Stock Titan
MapLight Therapeutics (MPLT) grants CSO new options and RSUs - stocktitan.net
MapLight Therapeutics (MPLT) lifts GC stake with 31K options - stocktitan.net
MapLight (MPLT) Reported Results Review: The EPS Result Is Below Expectation in the Reported Period; Trading-Day Reaction: Shares Rise 5.11% in Latest TradingGuidance Downgrade Alert - Vinanet
Catalyst4 builds 49.9% MapLight (MPLT) stake in private share deal - Stock Titan
MapLight Therapeutics, Inc. (MPLT) - Zacks Investment Research
MapLight Therapeutics announces $150M private placement - TipRanks
Morgan Stanley Maintains MapLight Therapeutics(MPLT.US) With Hold Rating, Maintains Target Price $21 - Moomoo
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Upgraded by Wall Street Zen - MarketBeat
LifeSci Capital Maintains MapLight Therapeutics(MPLT.US) With Buy Rating, Maintains Target Price $37 - Moomoo
BMO Capital Initiates MapLight Therapeutics(MPLT.US) With Buy Rating, Announces Target Price $20 - Moomoo
MapLight presses the pause button; ADC Therapeutics considers what to do with Zynlonta - Endpoints News
Finanzdaten der Maplight Therapeutics Inc-Aktie (MPLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Maplight Therapeutics Inc-Aktie (MPLT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Foff Erin Pennock | Chief Medical Officer |
Oct 15 '26 |
Sale |
8.08 |
15,355 |
124,068 |
296,906 |
| Kroeger Christopher A. | Chief Executive Officer |
Oct 15 '26 |
Sale |
8.08 |
73,691 |
595,423 |
1,195,909 |
| Lillie James Woodruff | Chief Scientific Officer |
Oct 15 '26 |
Sale |
8.08 |
11,513 |
93,025 |
198,597 |
| Lillie James Woodruff | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
11,513 |
89,917 |
0 |
| Kroeger Christopher A. | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
73,691 |
575,527 |
0 |
| GILLIS JONATHAN | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
10,167 |
79,404 |
0 |
| Hanson Kristopher | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
9,020 |
70,446 |
0 |
| Foff Erin Pennock | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
15,355 |
119,922 |
0 |
| GILLIS JONATHAN | CAO and Interim CFO |
Oct 15 '26 |
Sale |
8.08 |
10,167 |
82,149 |
142,315 |
| Anatol Kreitzer | Officer |
Oct 15 '26 |
Proposed Sale |
7.81 |
12,500 |
97,625 |
0 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):